Search

Search Constraints

You searched for: Author/Creator Su, M.

Search Results

1. 82P Preliminary analysis of tislelizumab (TIS) and chemotherapy as neoadjuvant therapy for potentially resectable stage IIIA/IIIB non-small cell lung cancer (NSCLC). (December 2022)